VRTX
Vertex Pharmaceuticals Incorporated
$383.13
+$0.01(+0.00%)
60
Overall
--
Value
60
Tech
--
Quality
Market Cap
$100.34B
Volume
1.47M
52W Range
$362.50 - $519.88
Target Price
$487.42
Key Metrics Overview
| Market Cap | $100.34B | P/E Ratio | 24.13 |
| 52W High | $519.88 | 52W Low | $362.50 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -30.6% | 52W Position | 13.1% |
| Overall Score | 60 | Value Score | -- |
| Quality Score | -- | Technical Score | 60 |
Growth Analysis
| EPS Current Est | $15.88 | EPS Next Est | $17.58 |
| EPS Growth Est | +10.7% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRTX | $383.13 | +0.0% | 1.47M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW